Clinical Trial Update: Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging [Phase 3]

View source ↗

Summary

Phase IIIb trial update for the Quadrivalent Recombinant HPV Vaccine (Hansenulapolymorpha) in bridging immunization schedules; trial is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Hansenulapolymorpha

Snippet

Sponsor: National Vaccine and Serum Institute, China | Conditions: Human Papillomavirus (HPV) Infection, HPV (Human Papillomavirus)-Associated Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING